A team of 19 researchers from Australia, Canada, Iceland, Singapore, and several European countries has completed what they call the “largest population-based study of absolute and relative risk of second malignant neoplasms (SMNs)” in childhood leukemia and lymphoma survivors.
Thanks to treatment advances, the majority of people diagnosed with Hodgkin’s disease ? often in youth or early adulthood ? can expect to survive long-term.
In recent years, researchers have worked to develop a number of vaccines to help the immune system fight tumors. Cancer vaccines are not intended to prevent cancer; rather, they are used to boost immune responses to preexisting tumors.
Relying on one of the largest collections of liver tissue samples ever acquired by a single organization, Geisinger Health System researchers have embarked on a massive study of one of the fastest growing liver problems.
A vaccine for treating a recurrent cancer of the central nervous system that occurs primarily in the brain has shown promise in preliminary data from a clinical trial at the University of California, San Francisco.
GlaxoSmithKline (NYSE: GSK) announced that the U.S. Food and Drug Administration (FDA) has approved its antibacterial Altabax for the topical treatment of impetigo due to susceptible strains of Staphylococcus aureus or Streptococcus pyogenes, the two most common types of bacteria in this kind of infection.
Immune cells that are the body?s front-line defense don?t necessarily rest quietly until invading bacteria lock onto receptors on their outside skins and rouse them to action, as previously thought.
A new study in Psychophysiology confirms a surprising fact ? men who have undergone chemical castration for conditions such as prostate cancer experience hot flashes similar to those experienced by menopausal women.
Gleevec, a pill developed in conjunction with Oregon Health & Science University is again showing excellent results in preventing cancer recurrence in GIST patients after complete removal of their tumors.
Researchers from Universit? Laval?s Faculty of Medicine have discovered that a compound commonly used in many antiwrinkle products causes a pathological reaction in skin cells.